Table 1.
Metabolite/ regulating step |
Cellular source |
Possible stimuli in lesion |
Effect on macrophages | Effect on atherosclerosis |
---|---|---|---|---|
Intracellular | ||||
Glucose/SLC2A1 | MΦ | Apoptotic cell, TLR4 ligands hypoxia | Altered inflammation and increased efferocytosis21, 50, 124 | Prevention of necrotic cores* (mouse)50, 124 |
Lactate | MΦ | TLR4 ligands, hypoxia, oxLDL | Resolution of inflammation16 | Unknown |
Non-oxPPP/SHPK | MΦ | IL-4 | Suppression of inflammatory activation17 | Unknown |
Succinate | MΦ | TLR4 ligands | IL-1β production | Unknown |
Citrate | MΦ | TLR4 ligands | TNF-α translation37 | Unknown |
α-ketoglutarate | MΦ | TLR4 ligands | LPS tolerance39 | Unknown |
Itaconate/ACOD1 | MΦ | TLR4 ligands | Resolution of inflammation and LPS tolerance41 | Unknown |
Oxaloacetate/citrate | MΦ | oxPAPC | IL-1β production64 | Promotes atherosclerosis^ (mouse)64 |
Arginine/Arg1 | MΦ | IL-4 | Promotes foam cell formation143 | No effect on atherosclerosis§ (mouse)143 |
Arginine/iNOS | MΦ | TLR4 ligands | Suppresses IL-12 production144 | Promotes lesion area§ (mouse)145 |
Serine | MΦ | TLR4 ligands | IL-1β production67, 68 | Unknown |
Acyl-CoA/ACSL1 | MΦ | TLR4 ligands, oxLDL | Promotes inflammatory activation86, 89 | Promotes lesion initiation* (diabetic mouse)86 |
Fatty acids/FAS | MΦ | oxysterols | Promotes lipid loading146 | Promotes atherosclerosis* (mouse)146 |
Fatty acids/FABP4 | MΦ | oxLDL | Promotes inflammatory activation and CE accumulation84 | Promotes lesion area§ (mouse)84 |
Mitochondrial ROS | MΦ | oxLDL | Promotes CCL2, IL-1β, and IL-6 production55, 78 | Promotes lesion initiation* (mouse)78 |
Associated with coronary artery disease (humans)55 | ||||
Intracellular | ||||
Lactate/SLC16A1 | MΦ cargo | Apoptotic cell | Resolution of inflammation50 | Unknown |
Lesional cells | Inflammation, hypoxia | |||
Succinate/ SUCNR1 | Lesional cells | TLR4 ligands | IL-1β28 | Unknown |
Arginine/putrescine | MΦ cargo | Apoptotic cell | Continual efferocytosis125 | Promotes lesion regression (mouse)125 |
CE, cholesteryl ester; HK1, hexokinase 1; MΦ, macrophage; non-oxPPP, non-oxidative phase of pentose phosphate pathway; SLC2A1, GLUT1
Myeloid cell targeted deletion or overexpression
Hematopoietic deletion (bone marrow transplant)
Indirect evidence